Return to Home Mortality > Table > Data Table

Data Table for Rate/Trend Comparison by State/County

Death Rate/Trend Comparison by State/County, 2016-2020

Georgia versus United States

All Races, Both Sexes

Sorted by priority index
Cancer Site and Sex
 sort alphabetically by cancer site ascending
Priority Index1
1=highest
9=lowest

 sort by priority index ascending
Recent Trend2
County Death
Rate
Compared
to
US Rate
Average Annual Count
 sort by count descending
Age-Adjusted Death Rate

deaths per 100,000
(95% Confidence Interval)
 sort by rate descending
Rate
Ratio3
County
to
US
 sort by rate descending
Recent 5-Year Trend2 in Death Rates
(95% Confidence Interval)
 sort by trend descending
Breast (Female) 8 falling falling trend similar 1,303 20.8 (20.3, 21.3) 1.1 -1.3 (-1.4, -1.2)
Cervix (Female) 8 falling falling trend similar 138 2.3 (2.1, 2.5) 1.1 -1.5 (-1.9, -1.2)
Childhood (Ages <20, All Sites) (Male) 8 falling falling trend similar 32 2.2 (1.9, 2.6) 0.9 -0.9 (-1.7, -0.2)
Colon & Rectum (Female) 8 falling falling trend similar 726 11.6 (11.2, 12.0) 1.1 -2.1 (-2.5, -1.8)
Colon & Rectum (Male) 8 falling falling trend similar 867 17.1 (16.6, 17.7) 1.1 -3.6 (-5.7, -1.4)
Esophagus (Female) 8 falling falling trend similar 85 1.3 (1.2, 1.5) 1.0 -2.1 (-2.5, -1.6)
Esophagus (Male) 8 falling falling trend similar 320 6.0 (5.7, 6.3) 0.9 -1.6 (-2.1, -1.1)
Kidney & Renal Pelvis (Female) 8 falling falling trend similar 142 2.2 (2.1, 2.4) 1.0 -0.8 (-1.3, -0.2)
Kidney & Renal Pelvis (Male) 8 falling falling trend similar 252 5.1 (4.8, 5.3) 1.0 -0.6 (-1.0, -0.1)
Leukemia (Female) 8 falling falling trend similar 265 4.3 (4.1, 4.6) 1.0 -1.3 (-1.6, -1.0)
Leukemia (Male) 8 falling falling trend similar 356 7.6 (7.3, 8.0) 1.0 -1.4 (-1.6, -1.1)
Lung & Bronchus (Female) 8 falling falling trend similar 1,870 28.9 (28.3, 29.5) 1.0 -3.3 (-3.8, -2.7)
Lung & Bronchus (Male) 8 falling falling trend similar 2,463 48.2 (47.3, 49.1) 1.1 -5.3 (-6.3, -4.2)
Melanoma of the Skin (Female) 8 falling falling trend similar 75 1.2 (1.1, 1.4) 0.9 -1.5 (-1.9, -1.1)
Melanoma of the Skin (Male) 8 falling falling trend similar 137 2.8 (2.6, 3.0) 0.9 -8.1 (-12.0, -4.0)
Non-Hodgkin Lymphoma (Female) 8 falling falling trend similar 223 3.6 (3.4, 3.8) 0.9 -2.7 (-3.2, -2.2)
Non-Hodgkin Lymphoma (Male) 8 falling falling trend similar 289 6.1 (5.8, 6.4) 0.9 -2.1 (-2.4, -1.7)
Ovary (Female) 8 falling falling trend similar 410 6.5 (6.2, 6.7) 1.0 -2.4 (-2.9, -2.0)
Prostate (Male) 8 falling falling trend similar 924 21.2 (20.6, 21.8) 1.1 -1.5 (-2.4, -0.5)
Stomach (Female) 8 falling falling trend similar 132 2.1 (2.0, 2.3) 1.0 -2.0 (-2.3, -1.6)
Stomach (Male) 8 falling falling trend similar 195 3.8 (3.5, 4.0) 1.0 -2.8 (-3.1, -2.5)
Bladder (Female) 6 stable stable trend similar 128 2.1 (1.9, 2.2) 1.0 -0.1 (-0.8, 0.5)
Brain & ONS (Female) 6 stable stable trend similar 213 3.4 (3.2, 3.6) 0.9 0.5 (-0.1, 1.1)
Childhood (Ages <15, All Sites) (Female) 6 stable stable trend similar 19 1.9 (1.5, 2.3) 1.0 -0.3 (-1.0, 0.5)
Childhood (Ages <15, All Sites) (Male) 6 stable stable trend similar 21 2.0 (1.6, 2.4) 0.9 -0.8 (-1.7, 0.1)
Childhood (Ages <20, All Sites) (Female) 6 stable stable trend similar 31 2.3 (1.9, 2.6) 1.1 0.1 (-0.8, 1.0)
Liver & Bile Duct (Male) 6 stable stable trend similar 516 9.4 (9.1, 9.8) 1.0 -0.3 (-2.5, 1.9)
Oral Cavity & Pharynx (Female) 6 stable stable trend similar 91 1.4 (1.3, 1.6) 1.0 0.3 (-1.9, 2.6)
Oral Cavity & Pharynx (Male) 6 stable stable trend similar 226 4.2 (3.9, 4.4) 1.1 -0.3 (-1.0, 0.4)
Pancreas (Male) 6 stable stable trend similar 649 12.7 (12.2, 13.1) 1.0 0.0 (-0.3, 0.3)
Thyroid (Female) 6 stable stable trend similar 27 0.4 (0.4, 0.5) 0.9 0.6 (-0.4, 1.5)
Bladder (Male) 2 rising rising trend similar 331 7.6 (7.2, 8.0) 1.1 0.7 (0.3, 1.0)
Brain & ONS (Male) 2 rising rising trend similar 276 5.3 (5.0, 5.6) 1.0 1.0 (0.2, 1.8)
Liver & Bile Duct (Female) 2 rising rising trend similar 258 4.0 (3.8, 4.2) 1.0 1.7 (1.4, 2.1)
Pancreas (Female) 2 rising rising trend similar 610 9.5 (9.2, 9.8) 1.0 0.2 (0.0, 0.4)
Thyroid (Male) 2 rising rising trend similar 25 0.5 (0.4, 0.6) 0.9 1.5 (0.4, 2.5)
Uterus (Corpus & Uterus, NOS) (Female) 2 rising rising trend similar 334 5.0 (4.8, 5.3) 1.0 2.6 (1.7, 3.5)
Notes:
Created by statecancerprofiles.cancer.gov on 05/02/2024 7:58 pm.

Trend2
     Rising     when 95% confidence interval of average annual percent change is above 0.
     Stable     when 95% confidence interval of average annual percent change includes 0.
     Falling     when 95% confidence interval of average annual percent change is below 0.
Rate Comparison
     Above     when 95% confident the rate is above and Rate Ratio3 > 1.10
     Similar     when unable to conclude above or below with confidence.
     Below     when 95% confident the rate is below and Rate Ratio3 < 0.90

1 Priority indices were created by ordering from rates that are rising and above the comparison rate to rates that are falling and below the comparison rate.
2 Recent trend in death rates is usually an Average Annual Percent Change (AAPC) based on the APCs calculated by Joinpoint Version 4.8.0.0. Due to data availability issues, the time period and/or calculation method used in the calculation of the trends may differ for selected geographic areas.
3 Rate ratio is the county rate divided by the US rate. Previous versions of this table used one-year rates for states and five-year rates for counties. As of June 2018, only five-year rates are used.
Source: Death data provided by the National Vital Statistics System public use data file. Death rates calculated by the National Cancer Institute using SEER*Stat. Death rates are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). The Healthy People 2020 goals are based on rates adjusted using different methods but the differences should be minimal. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used with mortality data.
Note: When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate. Suppression is used to avoid misinterpretation when rates are unstable.

State Cancer Registries may provide more current or more local data. Data presented on the State Cancer Profiles Web Site may differ from statistics reported by the State Cancer Registries (for more information).


Interpret Rankings provides insight into interpreting cancer statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data for United States does not include Puerto Rico.

Return to Top